DVA vs MCRB · P/E 14, rev $6.97B vs rev $1.1M
DaVita HealthCare Partners Inc (DVA) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the DVA and MCRB stock pages for the full models.
Not investment advice.